SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: UROGEN PHARMA LTD, UroGen Pharma Ltd.
Firm Income Reported for This Client
$400K
Not substituted for client expenses
SEC Insider
$17.2M
501 transactions
Summary
UROGEN PHARMA LTD. (URGN) is an organization, based in NJ. Its political footprint includes $400K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues. Political activity spans from 2020 to 2022.